शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
ENTEROBSEENTERO HEALTHCARE SOLU L· RetailingHighNeutral
Announced Fri, 7 Aug, 2026 · 17:53 IST

Q1 FY27 results approved, consolidated revenue up 38%, PAT up 72%

Revenue Growth 20pctPat Growth 25pctResults View source PDFExplain this filing

ENTERO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+5.0%Reaction day
₹1249.00
prior close
₹1333.00
announcement price
After-mkt
timing
Nifty Microcap 250market-0.1%+5.0% vs market
Retailing peers, median of 57sector · industry level+0.0%+5.0% vs sector

On the reaction day the stock moved 5.0 pts more than Nifty Microcap 250 and 5.0 pts more than its Retailing peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+5.6
10m
+1.8
15m
+1.0
30m
+1.6
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+5.0-0.1+5.0+0.0+5.0
Next day
+14.9-0.2+15.1+0.4+14.5
2d
+14.0+0.1+13.8-0.5+14.5
3d
+15.9+0.3+15.6-0.2+16.1
4d
+13.9+0.4+13.5-0.3+14.2
5d
+12.2+0.5+11.7-0.0+12.2
1w
+11.6+0.3+11.3-1.2+12.8
15d
+44.1+1.9+42.3+0.1+44.1
1m
+48.1+2.2+45.9-1.3+49.5
2m
+31.4-1.2+32.5-5.2+36.6
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Retailing peers, median of 57Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved Q1 FY27 (June 2026) results. Consolidated revenue from operations rose 38 percent YoY to Rs 1,940 crore, boosted by subsidiary additions during FY26. Consolidated PAT grew 72 percent to Rs 52 crore; EPS at Rs 8.77 versus Rs 6.39. Standalone PAT fell sharply to Rs 3.5 crore from Rs 13.4 crore due to higher finance costs and lower other income. Auditor gave an unmodified opinion. Board committees were reconstituted after independent director Rajesh Dalal's tenure ends on August 24.

Likely market impact

Strong consolidated growth from acquisitions is positive, but standalone weakness from higher finance costs warrants attention on margin trends.